Skip to Main Content

Paper Details

Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
J Clin Oncol
23
2018
Asplenic, Childhood Cancer, asplenia, childhood cancer, impaired splenic function, splenic
Author NameAffiliation
Arin L MadenciBoston Children's Hospital Brent R. Weil, Harvard Medical School Brent R. Weil, Dana-Farber Cancer Institute Arin L. Madenci, Brigham and Women's Hospital, University of Alberta, The University of Texas MD Anderson Cancer Center, St Jude Children's Research Hospital, University of Minnesota, Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, University of Rochester Medical Center, Duke University
Rebecca M HowellBoston Children's Hospital Brent R. Weil, Harvard Medical School Brent R. Weil, Dana-Farber Cancer Institute Arin L. Madenci, Brigham and Women's Hospital, University of Alberta, The University of Texas MD Anderson Cancer Center, St Jude Children's Research Hospital, University of Minnesota, Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, University of Rochester Medical Center, Duke University
Joseph P NegliaBoston Children's Hospital Brent R. Weil, Harvard Medical School Brent R. Weil, Dana-Farber Cancer Institute Arin L. Madenci, Brigham and Women's Hospital, University of Alberta, The University of Texas MD Anderson Cancer Center, St Jude Children's Research Hospital, University of Minnesota, Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, University of Rochester Medical Center, Duke University
Joseph P NegliaBoston Children's Hospital Brent R. Weil, Harvard Medical School Brent R. Weil, Dana-Farber Cancer Institute Arin L. Madenci, Brigham and Women's Hospital, University of Alberta, The University of Texas MD Anderson Cancer Center, St Jude Children's Research Hospital, University of Minnesota, Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, University of Rochester Medical Center, Duke University
Susan A SmithBoston Children's Hospital Brent R. Weil, Harvard Medical School Brent R. Weil, Dana-Farber Cancer Institute Arin L. Madenci, Brigham and Women's Hospital, University of Alberta, The University of Texas MD Anderson Cancer Center, St Jude Children's Research Hospital, University of Minnesota, Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, University of Rochester Medical Center, Duke University
Gregory T ArmstrongBoston Children's Hospital Brent R. Weil, Harvard Medical School Brent R. Weil, Dana-Farber Cancer Institute Arin L. Madenci, Brigham and Women's Hospital, University of Alberta, The University of Texas MD Anderson Cancer Center, St Jude Children's Research Hospital, University of Minnesota, Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, University of Rochester Medical Center, Duke University
Gregory T ArmstrongBoston Children's Hospital Brent R. Weil, Harvard Medical School Brent R. Weil, Dana-Farber Cancer Institute Arin L. Madenci, Brigham and Women's Hospital, University of Alberta, The University of Texas MD Anderson Cancer Center, St Jude Children's Research Hospital, University of Minnesota, Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, University of Rochester Medical Center, Duke University
  • 1 - 7

Datasets